Gastroenterology CRO for Clinical Research
With extensive global expertise in the design and medical oversight of gastroenterology clinical trials, Medpace is well-positioned to help our clients develop new and effective treatments for digestive disorders and diseases. Medpace is the gastroenterology CRO that helps our clients:
- Optimize clinical trial design
- Proactively assess and meet potential regulatory challenges
- Standardize patient inclusion and efficacy outcome assessment
Experience in all major gastroenterology indications, spanning both adult and pediatric populations.
- Inflammatory Bowel Disease including:
- Ulcerative Colitis
- Crohn's Disease
- Functional GI Disorders including:
- Chronic Idiopathic Constipation (also drug-induced constipation)
- Irritable Bowel Syndrome
- Postprandial Distress and Gastroparesis (also GERD)
- Liver Disease including:
- Viral Hepatitis
- Nonalcoholic steatohepatitis (NASH)
The Medpace Difference for Gastroenterology Studies
In addition to the Medpace Difference that applies to all of our therapeutic areas, our gastroenterology clients benefit from:
- Gastroenterology medical expert with a background in both hospital-based clinical practice and pharmaceutical development.
- Recognized in the field for his contribution to the pioneering work on standardization of central imaging in inflammatory bowel disease drug development.
- Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom.
- Centralized imaging services for efficient, cost-effective assessment of efficacy outcomes.
- Global central laboratories that can help design and execute your protocol testing needs with a strong selection of inflammatory biomarkers and cytokines.